97 related articles for article (PubMed ID: 219123)
1. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits.
Kessler CM; Bell WR
J Lab Clin Med; 1979 May; 93(5):768-82. PubMed ID: 219123
[TBL] [Abstract][Full Text] [Related]
2. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
Kessler CM; Bell WR
J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
[TBL] [Abstract][Full Text] [Related]
3. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen synthesis in rabbits: effects of altered levels of circulating fibrinogen.
Alving BM; Bell WR; Evatt BL
Am J Physiol; 1977 May; 232(5):H478-84. PubMed ID: 860765
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen fragments X, Y, D and E increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats.
Princen HM; Moshage HJ; Emeis JJ; de Haard HJ; Nieuwenhuizen W; Yap SH
Thromb Haemost; 1985 Apr; 53(2):212-5. PubMed ID: 4024030
[TBL] [Abstract][Full Text] [Related]
7. Separation of fibrinogen degradation products (FDP) by means of adsorption to insolubilized fibrinmonomer (FM-ag).
Heene DL; Matthias FR; Wegrzynowicz Z; Hocke G
Thromb Haemost; 1979 Jun; 41(4):677-86. PubMed ID: 483241
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
Chi DS; Chen JP
Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of fibrinogen synthesis in cultured rat hepatocytes by fibrinogen degradation product fragment D.
LaDuca FM; Tinsley LA; Dang CV; Bell WR
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8788-92. PubMed ID: 2813424
[TBL] [Abstract][Full Text] [Related]
11. Effect of fibrin degradation products and thrombin on fibrinogen synthesis.
Ittyerah TR; Weidner N; Wochner RD; Sherman LA
Br J Haematol; 1979 Dec; 43(4):661-8. PubMed ID: 526446
[TBL] [Abstract][Full Text] [Related]
12. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
13. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
Chen JP; Williams TK; Legendre AM
Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
[TBL] [Abstract][Full Text] [Related]
15. [Preparation and separation of milligram amounts of canine fibrin(ogen) degradation products (fdp) X, Y, D and E].
Wolling H; Mischke R
Berl Munch Tierarztl Wochenschr; 1995 Nov; 108(11):421-6. PubMed ID: 8593135
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
[TBL] [Abstract][Full Text] [Related]
17. Unreliability of current serum fibrin degradation product (FDP) assays.
Gaffney PJ; Perry MJ
Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
[TBL] [Abstract][Full Text] [Related]
18. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
Chek JB; Panchenko NI
East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
[TBL] [Abstract][Full Text] [Related]
20. The effects of infusion of thrombin or endotoxin in rabbits treated with cortisone.
Stafford BT; Rapaport SI; Shen SM
Thromb Diath Haemorrh; 1975 Sep; 34(1):159-68. PubMed ID: 1188709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
